Safety and efficacy of directly‐acting antiviral therapy for chronic hepatitis C virus in elderly people
Abstract Introduction In Italy, the prevalence of hepatitis C virus (HCV) infection is higher in the elderly, although the efficacy and safety of treatment in this population has not been extensively studied. Moreover, little is known about how much pharmacological interaction affects eligibility to...
Main Authors: | Adriano De Santis, Daniela Maggi, Federica Lubrano Lobianco |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-12-01
|
Series: | Aging Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/agm2.12190 |
Similar Items
-
Reactivation of herpesvirus in patients with hepatitis C treated with direct-acting antiviral agents
by: Ghweil AA, et al.
Published: (2019-04-01) -
Aggressive recurrence of Non-Hodgkin's Lymphoma after successful clearance of hepatitis C virus with direct acting antivirals
by: Dimitrios N. Samonakis, et al.
Published: (2021-03-01) -
Curing Chronic Hepatitis C: A Cost Comparison of the Combination Simeprevir Plus Sofosbuvir vs. Protease-Inhibitor-Based Triple Therapy
by: Jacob A. Langness, et al.
Published: (2017-05-01) -
Real-World Effectiveness and Safety of Direct-Acting Antivirals in Patients with Chronic Hepatitis C and Epilepsy: An Epi-Ter-2 Study in Poland
by: Monika Pazgan-Simon, et al.
Published: (2023-07-01) -
Improvement of patient-reported outcomes in patients achieving sustained virologic response with direct-acting antivirals for hepatitis C virus infection
by: Chih-Hsun Yi, et al.
Published: (2022-08-01)